MedPath

澳美製藥廠有限公司

Ownership
-
Established
1993-09-02
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

111

NMPA:111

Drug Approvals

Fusidic Acid Cream

Product Name
奥络
Approval Number
国药准字HC20150043
Approval Date
Apr 2, 2025
NMPA

Fusidic Acid Cream

Product Name
奥络
Approval Number
国药准字HC20150044
Approval Date
Apr 2, 2025
NMPA

Ambroxol Hydrochloride Oral Solution

Product Name
盐酸氨溴索口服溶液
Approval Number
国药准字HC20255001
Approval Date
Jan 27, 2025
NMPA

肚痛泻丸

Approval Number
国药准字ZC20150008
Approval Date
Dec 20, 2024
NMPA

肚痛泻丸

Approval Number
国药准字ZC20150007
Approval Date
Dec 20, 2024
NMPA

Compound Pholcodine Oral Solution

Product Name
澳特斯
Approval Number
国药准字HC20150059
Approval Date
Sep 5, 2024
NMPA

Compound Pholcodine Oral Solution

Product Name
澳特斯
Approval Number
国药准字HC20150058
Approval Date
Sep 5, 2024
NMPA

Compound Pholcodine Oral Solution

Product Name
澳特斯
Approval Number
国药准字HC20150060
Approval Date
Sep 5, 2024
NMPA

Compound Pholcodine Oral Solution

Product Name
澳特斯
Approval Number
国药准字HC20150057
Approval Date
Sep 5, 2024
NMPA

Dihydrocodeine Bitartrate Tablets

Product Name
酒石酸双氢可待因片
Approval Number
国药准字HC20240006
Approval Date
Jun 18, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 12
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.